BLACKROCK Municipal Income TRUST V.BFK.P

Primary Symbol: BFK

BlackRock Municipal Income Trust (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income taxes. Under normal market conditions, the Fund invests at least 80% of its managed assets in investments the income from which is exempt from federal income tax (except that the interest may be subject to the alternative minimum tax). The Fund may invest directly in securities or synthetically through the use of derivatives. The Fund's investment policies provide that it invests at least 80% of its total assets in investment grade quality municipal obligations issued by or on behalf of states, territories and possessions of the United States and their political subdivisions, agencies or instrumentalities, each of which pays interest that, in the opinion of bond counsel to the issuer, is excludable from gross income for federal income tax purposes. Its investment adviser is BlackRock Advisors, LLC.

NYSE:BFK - Post by User

BLACKROCK Municipal Income TRUST > Lisa Marie Langevin ???

<< Previous

Bullboard Posts

Next >>

Comment by HARJAYon Jun 21, 2020 10:51am

133 Views

Post# 31174184

RE:RE:Lisa Marie Langevin ???

I presume you are talking about this one.

$500M LAWSUIT ACCUSES CANNABIS RETAILERS OF DISTRIBUTING PRODUCT WITH INCORRECT THC AND CBD LEVELS

CTVNEWSCALGARY.CA SENIOR DIGITAL PRODUCER/DIGITAL LEAD

Ryan White

Friday, June 19th 2020 - 1:24 pm

According to the statement of claim, a bottle of Canaca-TenUp oil bought at a store in northwest Calgary in February 2020 was found to have only 46 per cent of the THC level stated on the bottle (supplied)

A class-action lawsuit filed in Calgary against cannabis companies claims the THC and CBD levels in their medicinal and recreational cannabis products differed from what was represented on packaging.

According to the statement of claim filed at the Judicial Centre of Calgary on Tuesday, June 16, the companies allegedly sold cannabis products to Canadian consumers with drastically different THC (tetrahydrocannabinol) or CBD (cannabidiol) levels than advertised on the label.

The defendants named in the lawsuit are:

Aurora Cannabis Inc.
Aurora Cannabis Enterprises Inc.
AuroraCo.
Aleafiaco
Aleafia Health Inc.
Emblem Cannabis Corp.
Hexo Corp.
HexoCo
Cronos Group Inc.
Cronosco
Tilray Canada Ltd.
Organigram Holdings Inc.
OrganigramCo
MediPharm Labs Corp.
MediPharmCo

The document indicates that THC and CBD levels were found to be significantly higher than indicated in some products while others may have had significantly lower levels as a result of absorption or degradation due to the use of plastic bottles.

The lawsuit is seeking $500 million in compensation for Canadians who purchased medicinal cannabis products between now and June 16, 2010 as well as Canadians who legally purchased cannabis for recreational purposes since Oct. 17, 2018.

Lisa Marie Langevin is named as the plaintiff representing the class-action. The Calgary woman claims to have purchased a cannabis oil from a northwest store in mid-February 2020 at the recommendation of a staff member.

Langevin says it was her first time trying cannabis and she did not feel any psychotropic effects after using the product four times and increasing the dosage, over the period of a month. She then consulted a friend of hers, a doctor, who also tried the product and felt nothing.

According to the statement of claim, the doctor arranged to have both the product and the plastic vial tested and it was determined that the product only had 46 per cent of the active THC level indicated on the vial's label.

The allegations outlined in the lawsuit have not been tried in court.